Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00675623 · ClinicalTrials.gov registry record · Phase 3
A Safety and Efficacy Study of Oral Dimebon in Patients With Mild-To-Moderate Alzheimer's Disease
A Phase 3 study, sponsored by Medivation.
- Completed
- Registry status
- Phase 3
- Development phase
- 598
- Enrollment target
NCT00675623 is a Phase 3 study that has completed, run by Medivation. The registered enrollment target is 598 participants.
The verdict
NCT00675623, a Phase 3 study, has completed, sponsored by Medivation.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 598 participants
- Enrollment target
Study Summary
The Connection Study is a six-month confirmatory Phase 3 study to determine the safety and efficacy of Dimebon in the treatment of mild-to-moderate Alzheimer's disease (AD).
Interventions
- DRUG Placebo
- DRUG Dimebon
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 598 participants |
| Start Date | 2008-05 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00675623
The ClinicalTrials.gov registry entry for NCT00675623 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 598 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medivation, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00675623 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00675623 about?
NCT00675623 is a clinical study titled "A Safety and Efficacy Study of Oral Dimebon in Patients With Mild-To-Moderate Alzheimer's Disease". The Connection Study is a six-month confirmatory Phase 3 study to determine the safety and efficacy of Dimebon in the treatment of mild-to-moderate Alzheimer's disease (AD).
What is the current status of trial NCT00675623?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 598 participants. The study started on 2008-05.
What interventions are being tested in trial NCT00675623?
The interventions under investigation include: Placebo (DRUG), Dimebon (DRUG).
Who is sponsoring clinical trial NCT00675623?
This trial is sponsored by Medivation, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.